The global surgical gowns market is expected to grow at a CAGR of 3.09% over the forecast period to reach US$3,040.535 million by 2030 from $1,702.758 million in 2025. When in surgical procedures, medical surgeons...
The global surgical gowns market is expected to grow at a CAGR of 3.09% over the forecast period to reach US$3,040.535 million by 2030 from $1,702.758 million in 2025.
When in surgical procedures, medical surgeons and healthcare professionals wear special clothes called surgical gowns for protective purposes, where such gowns are used on patients to avoid many bacteria or infections that would further harm their health. That is provided on demand, and the dresses are made up of special fabrics such as cotton and woven polyester, which provide them with a higher degree of comfort.
Global market growth will be attributed to healthcare-acquired infections (Hais), increasing demands for patient safety and comfort, and soaring healthcare expenditures. For instance, seven patients in high-income countries and fifteen patients in low- and middle-income countries will get at least one HAI during their hospital stay out of every 100 patients in acute-care hospitals. Of affected people, approximately 10% will end up dying due to HAI.
Moreover, surgical gowns are highly useful in the control of HAIs, providing general protection against contamination. Acting as a barrier, they prevent the entry of bacteria and other microbiological illnesses into a patient's body. Surgeons will advise these patients to wear such types of gowns before medical procedures, thus entailing their increase in growth over the forecast period.
Immediate medical attention after a traumatic incident, including traffic accidents. The hospital gown becomes a universally recognized outfit used by medical practitioners in their various examinations and treatments, as hospitals should provide gowns to these patients in emergencies. The increased number of accidents drives the demand for medical services, thus making it urgent to improve and expand healthcare facilities. Such an increase will likely heighten the demand for hospital gowns because of the advancements made in healthcare. Additionally, classical surgical gowns, besides being very uncomfortable, make pediatric patients feel exposed or even ashamed during that already painful moment. Starlight Gowns are made from a luxurious fabric that is very nice to the skin. These gowns have easy access for medical procedures since they have plastic snaps on both the shoulders and ties on each side. Initiatives like this spread the industry like wildfire.
Another major driving factor in this market is the growing demand for comfort and safety in patients. Disposable and antimicrobial hospital gowns create a barrier between patients and potentially dangerous microbes and reduce the chances of infection, which is of utmost importance for patients undergoing surgery and for those with compromised immune systems.
The global surgical gowns market is segmented by fabric type into three major categories: cotton, polyester, and others. Hospitals and clinics have increased their interest in other options such as washable, breathable, and environmentally friendly surgical gowns. Hence for noncritical procedures, cotton is indeed a good option. Cotton gowns are eco-friendly and reusable, which resonates very well with the increasing focus of the healthcare industry on sustainable practices. Surgical gowns made of cotton are cheaper than some synthetic alternatives. Many institutions are opting for reusable cotton gowns to cut costs and reduce waste. Policies encouraging the utilization of eco-friendly materials in health care may increase the demand for cotton surgical gowns. Cotton gowns are generally the option of developing countries with limited resources because they are cheap but long-lasting.
The global surgical gowns market by gown type is segmented into surgical isolation, non-reinforced gown, reinforced gown, and others When there is a medium to high risk of contamination and larger critical zones are required than with standard surgical gowns, surgical isolation gowns are utilized. Similar to surgical gowns, surgical isolation gowns are governed by FDA regulations as Class II medical devices, which necessitate a 510(k) premarket notification.
Moreover, in low-risk or minimal-risk patient isolation scenarios, non-surgical isolation gowns are Class I devices designed to shield the wearer from the spread of bodily fluids and microorganisms. When there is a medium to high risk of contamination, non-surgical gowns are not worn during invasive procedures or surgeries.
The global surgical gowns market by usage pattern is segmented into reusable and disposable. Disposable gowns have been used in hospitals only once, so they are cost-effective. In terms of quality and safety, these gowns are highly recommended compared with reusables. Also, they do away with the conditioning, bleaching, and washing costs of reusable gowns. Disposable gowns are hypoallergenic and dermatologist-approved.
It sustains a sterile environment and maintains a germ-free participatory operating room. Normally, such gowns are used for single use, thereby reducing the chances of cross-contamination between patients and providers. Disposable gowns are also used to prevent the transfer of infections from one patient to another.
The global surgical gowns market by end-user is segmented into hospitals & clinics and ambulatory surgical centres. Surgical gowns, however, meet specific standards to be utilized in a variety of medical and surgical procedures. For example, manufacturers of surgical gowns must adhere to the FDA's Recognized Consensus Standards, which include sterility and biocompatibility requirements. The European Committee for Standardization of the European Union has established similar rules. Such rules and regulations may impede the expansion of the surgical gown market globally.
Based on geography, the North American region of the global surgical gowns market is growing significantly. High-quality surgical gowns and other biomedical textiles are essential to the healthcare infrastructure of North America, especially in the US and Canada. The region's market dominance is increased by the strict infection control regulations and regulatory agencies such as Health Canada and the FDA, which guarantee the efficacy and safety of medical textiles.
The demand for surgical gowns is further fueled by the high levels of healthcare expenditure and the prevalence of chronic diseases. Important market participants guarantee a consistent flow of surgical gowns, encouraging competition and innovation.
Moreover, medical textiles are also seeing technological breakthroughs, with continuous research fostering the development of novel surgical gown components, styles, and attributes. The dominance of the North American healthcare market affects both domestic and international market dynamics.
As a part of the report, the major players operating in the Global surgical gowns market that have been covered are Cardinal Health, CWS International GmbH, Molnlycke Health Care AB, O&M Halyard, Priontex, Cortex Products Solution Pvt. Ltd, Thermo Fisher Scientific, 3M, Medica Europe BV, Whelehan Group.
View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/global-surgical-gowns-market
The market analytics report segments the global surgical gowns market as follows:
- By Fabric Type
- Cotton
- Polyester
- Others
- By Gown Type
- Surgical Isolation
- Non-Reinforced Gown
- Reinforced Gown
- Others
- By Usage Pattern
- Reusable
- Disposable
- By End-User
- Hospitals & Clinics
- Ambulatory Surgical Center
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- Israel
- United Arab Emirates
- Others
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Taiwan
- Others
- North America
- Medical Bed Market Size
- Synthetic Surgical Glove Market Size
- Polyisoprene (PI) Surgical Glove Market Size
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.
